Clinical Trial Finder

Many patients with prediabetes are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study

Conditions:   Pre-diabetes;   Obesity
Interventions:   Behavioral: HELP Vets Intervention;   Behavioral: Individual Education Program
Sponsors:   Wake Forest School of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   VA Office of Research and Development
Not yet recruiting - verified July 2016

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Condition:   Obesity
Interventions:   Drug: NNC9204-0530;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Not yet recruiting - verified July 2016

Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome

Condition:   Pre Diabetes
Interventions:   Dietary Supplement: BGG;   Other: Placebo
Sponsors:   Vedic Lifesciences Pvt. Ltd.;   Healthy Directions, LLC
Completed - verified July 2016

Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)

Conditions:   Pre-diabetes;   Diabetes
Intervention:   Procedure: Not applicable. This is an observational study.
Sponsors:   Medicine;   Janssen Pharmaceuticals;   National Medical Research Council (NMRC), Singapore
Recruiting - verified July 2016

Wolfram Syndrome International Registry and Clinical Study

Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
Recruiting - verified July 2016

Impact of Sleep Restriction in Women

Conditions:   Sleep;   Cardiovascular Disease;   Obesity
Intervention:   Other: Sleep Restriction
Sponsors:   Columbia University;   American Heart Association
Not yet recruiting - verified July 2016

PREventive Care Infrastructure Based On Ubiquitous Sensing (PRECIOUS). VHIR Pilot.

Condition:   Obesity
Interventions:   Behavioral: Intervention 1;   Behavioral: Intervention 2
Sponsors:   Hospital Universitari Vall d'Hebron Research Institute;   Aalto University;   Helsinki University;   Firstbeat Technologies Ltd.;   University of Vienna;   Telecom Bretagne;   Campden BRI;   EuroFIR
Active, not recruiting - verified July 2016

Type 1 Diabetes Extension Study

Conditions:   Type 1 Diabetes;   Diabetes Mellitus
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Recruiting - verified July 2016

Glucose Tolerance in Children With Cystic Fibrosis

Conditions:   Glucose Intolerance;   Cystic Fibrosis
Intervention:   Other: Diagnostics for glucose tolerance with 3 different methods.
Sponsors:   Christoph Saner;   University Hospital Inselspital, Berne
Active, not recruiting - verified July 2016

Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance

Condition:   Insulin Resistance
Interventions:   Behavioral: healthy lifestyle;   Drug: Metformin
Sponsor:   Beijing Tsinghua Chang Gung Hospital
Recruiting - verified July 2016

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study

Condition:   Type 2 Diabetes
Interventions:   Other: Low carbohydrate meals;   Other: Standard carbohydrate meals
Sponsor:   Bispebjerg Hospital
Recruiting - verified July 2016

Effectiveness of Automated Mobile Phone Based Text Messaging on the Improvement of Glycaemic Outcomes

Condition:   Type 2 Diabetes Mellitus
Interventions:   Behavioral: Mobile phone text messaging;   Other: Conventional care
Sponsor:   India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Active, not recruiting - verified July 2016

Effect of Dietary Habits on Metabolic Health

Conditions:   Overweight;   Obesity;   Prediabetes;   Meals
Intervention:   Behavioral: Meal schedule
Sponsors:   Brigham and Women's Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2016

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

Condition:   Fatty Liver
Intervention:   Drug: Aramchol
Sponsors:   Galmed Pharmaceuticals Ltd;   Sharp Clinical Services;   Diamond Pharma Services;   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   ClinIntel;   Itamar-Medical, Israel;   One Way Liver OWL;   Medical University of Graz;   Tel-Aviv Sourasky Medical Center;   DSG EDC;   TransPerfect;   Clinical Reference Laboratory
Recruiting - verified July 2016

Continuous Glucose Monitoring in Controls With and Without Cystic Fibrosis

Condition:   Cystic Fibrosis
Sponsor:   University of Colorado, Denver
Recruiting - verified July 2016

Structured Aerobic and Resistance Exercise and Gestational Diabetes

Condition:   Gestational Diabetes Mellitus
Intervention:   Other: Structured Exercise
Sponsor:   Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse
Completed - verified July 2016

Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness

Conditions:   Diabetes Mellitus, Type 2;   Schizophrenia
Interventions:   Drug: Metformin;   Drug: Placebo
Sponsor:   Centre for Addiction and Mental Health
Recruiting - verified July 2016

Acetylcarnitine and Metabolic Flexibility

Condition:   Glucose Intolerance
Interventions:   Dietary Supplement: Carnitine supplement;   Dietary Supplement: Placebo
Sponsors:   Maastricht University Medical Center;   European Foundation for the Study of Diabetes
Completed - verified June 2015

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Conditions:   Type 2 Diabetes;   Cardiovascular Disease
Interventions:   Drug: Sitagliptin;   Drug: Glimepiride;   Drug: Placebo;   Drug: Placebo
Sponsors:   University of Colorado, Denver;   Merck Sharp & Dohme Corp.
Recruiting - verified July 2016

Effect of Exercise on Insulin Resistance

Condition:   Prediabetic State
Interventions:   Behavioral: Current Recommendations Exercise Group;   Behavioral: Intensive Exercise Group
Sponsor:   Alere San Diego
Terminated - verified July 2016

Function of Metformin at the Cellular Level and Best Dosing for Children and Adults With DM or Pre-DM

Conditions:   Diabetes;   Pre-diabetes;   Obesity
Intervention:   Drug: Metformin
Sponsor:   Johns Hopkins University
Terminated - verified February 2016

Postpartum Weight Loss and Exercise (PRIDE)

Conditions:   Gestational Diabetes;   Glucose Intolerance
Interventions:   Behavioral: Non-intervention group;   Behavioral: Face to face;   Behavioral: Telehelath Group
Sponsors:   Pennington Biomedical Research Center;   THE C.B. AND IRENE PENNINGTON FOUNDATION
Recruiting - verified July 2016